Page last updated: 2024-11-01

omeprazole and Anemia, Megaloblastic

omeprazole has been researched along with Anemia, Megaloblastic in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellou, A1
Aimone-Gastin, I1
De Korwin, JD1
Bronowicki, JP1
Moneret-Vautrin, A1
Nicolas, JP1
Bigard, MA1
Guéant, JL1

Other Studies

1 other study available for omeprazole and Anemia, Megaloblastic

ArticleYear
Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy.
    Journal of internal medicine, 1996, Volume: 240, Issue:3

    Topics: Anemia, Megaloblastic; Enzyme Inhibitors; Gastroesophageal Reflux; Hematinics; Humans; Malabsorption

1996